Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial
Sign Up to like & getrecommendations! Published in 2017 at "JAMA Psychiatry"
DOI: 10.1001/jamapsychiatry.2017.1220
Abstract: Importance Compared with the general population, patients with schizophrenia have a 2- to 3-fold higher mortality rate primarily caused by cardiovascular disease. Previous interventions designed to counteract antipsychotic-induced weight gain and cardiometabolic disturbances reported limited… read more here.
Keywords: schizophrenia spectrum; clozapine olanzapine; trial; patients schizophrenia ... See more keywords
Association Between Retinal Features From Multimodal Imaging and Schizophrenia.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA psychiatry"
DOI: 10.1001/jamapsychiatry.2023.0171
Abstract: Importance The potential association of schizophrenia with distinct retinal changes is of clinical interest but has been challenging to investigate because of a lack of sufficiently large and detailed cohorts. Objective To investigate the association… read more here.
Keywords: association retinal; multimodal imaging; patients schizophrenia; retinal features ... See more keywords
Anti‐TSNARE1 IgG plasma levels differ by sex in patients with schizophrenia in a Chinese population
Sign Up to like & getrecommendations! Published in 2019 at "FEBS Open Bio"
DOI: 10.1002/2211-5463.12704
Abstract: It was recently reported that levels of plasma IgG antibodies against peptide antigens derived from proteins encoded by schizophrenia‐associated genes are altered in individuals with schizophrenia treated with antipsychotics. This study aimed to replicate the… read more here.
Keywords: patients schizophrenia; tsnare1 igg; plasma; anti tsnare1 ... See more keywords
Factor analysis of the relationship between PANSS score and family burden of patients with schizophrenia
Sign Up to like & getrecommendations! Published in 2021 at "Brain and Behavior"
DOI: 10.1002/brb3.2229
Abstract: This study aims to investigate the burden of family caregivers of patients with schizophrenia, and its influencing factors read more here.
Keywords: relationship panss; patients schizophrenia; factor analysis; analysis relationship ... See more keywords
Aberrant neural networks for the recognition memory of socially relevant information in patients with schizophrenia
Sign Up to like & getrecommendations! Published in 2017 at "Brain and Behavior"
DOI: 10.1002/brb3.602
Abstract: Patients with schizophrenia exhibit several cognitive deficits, including memory impairment. Problems with recognition memory can hinder socially adaptive behavior. Previous investigations have suggested that altered activation of the frontotemporal area plays an important role in… read more here.
Keywords: recognition memory; memory; socially relevant; patients schizophrenia ... See more keywords
Pharmacokinetics and Safety of Risperidone Subcutaneous Implants in Stable Patients With Schizophrenia
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.428
Abstract: A subcutaneous risperidone implant (RI) formulation was developed to improve medication adherence in schizophrenia. Two phase 1 studies were conducted to evaluate the pharmacokinetics of RI in adult patients with schizophrenia. In study 1, all… read more here.
Keywords: concentration; pharmacokinetics safety; oral risperidone; patients schizophrenia ... See more keywords
Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Geriatric Psychiatry"
DOI: 10.1002/gps.4818
Abstract: Motivational deficits are prevalent in patients with schizophrenia, persist despite antipsychotic treatment, and predict long‐term outcomes. Evidence suggests that patients with greater amotivation have smaller ventral striatum (VS) volumes. We wished to replicate this finding… read more here.
Keywords: striatum volumes; ventral striatum; patients schizophrenia; smaller ventral ... See more keywords
Prediction of physiological state, cognition, sensory function, and biomarkers for frailty in patients aged 55 years or more with schizophrenia.
Sign Up to like & getrecommendations! Published in 2023 at "Nursing open"
DOI: 10.1002/nop2.1741
Abstract: AIM We explored the performance of demographic characteristics, physiological state, cognitive function, sensory function, and biomarkers when used as predictors of frailty for patients with schizophrenia. DESIGN A cross-sectional study design was adopted. METHODS Demographic… read more here.
Keywords: patients schizophrenia; function; physiological state; sensory function ... See more keywords
Risk factors for pneumonia in patients with schizophrenia
Sign Up to like & getrecommendations! Published in 2018 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12034
Abstract: Pneumonia is a major cause of death in patients with schizophrenia. Preventive strategies based on identifying the risk factors are needed to reduce pneumonia‐related mortality. This study aimed to clarify the risk factors for pneumonia… read more here.
Keywords: patients schizophrenia; factors pneumonia; risk factors; pneumonia patients ... See more keywords
Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8‐week, multicenter, double‐blind, randomized controlled study
Sign Up to like & getrecommendations! Published in 2019 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12089
Abstract: To report the efficacy and safety of blonanserin in patients with schizophrenia compared with risperidone in a Japanese multicenter, randomized, double‐blind study based on post hoc sensitivity analysis in addition to the previous results reported… read more here.
Keywords: post hoc; patients schizophrenia; risperidone japanese; study ... See more keywords
Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study
Sign Up to like & getrecommendations! Published in 2022 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12304
Abstract: We aimed to compare neuropeptide levels between patients with major psychiatric disorders and healthy controls and examine their association with symptoms and cognitive function. read more here.
Keywords: plasma neuropeptide; healthy controls; patients schizophrenia; neuropeptide levels ... See more keywords